Biomarkers in Gastroesophageal cancer 2025 – An updated consensus statement by the SEOM and SEAP

Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared an article Maria Alsina Maqueda and colleagues authored on X:

“Biomarkers in gastroesophageal cancer 2025: an updated consensus statement by the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

4 key biomarkers: HER2, dMMR/MSI, PD-L1 and Claudin18.2 by inmunohistochemistry.”